.
| INTRODUCTION
A comprehensive quality management program in a radiotherapy clinic utilizing external beam radiation therapy will include performance testing of a linear accelerator (linac) . The linac must be tested routinely to ensure that current performance parameters have not deviated from baseline clinical parameters acquired at the time of acceptance of the machine. More importantly, it must be validated that the beam models in the treatment planning system (TPS) are still appropriate for the linac in its current operating state.
The technology and control systems within a linac are rapidly evolving and new features emerge frequently to assist the user in accurately and efficiently treating patients. The specific choice and use of technology on a linac will depend on the types of diseases treated, the clinical workload, and workflow. The performance tests on a linac should be selected to fit the clinical patterns of use of the accelerator and care should be given to perform tests which are relevant to detecting errors related to the specific use of the accelerator. Committee members of this guideline reviewed the current protocols for performance tests on a linac. A risk assessment was performed on currently recommended tests in order to identify those tests which will enable the greatest detection of errors, the delivery of high-quality radiation therapy and reflect the characteristics of modern technology.
| GOALS AND RATIONALE
This report describes dosimetry, mechanical, and safety tests for C-arm type linacs only. Specialized systems such as CyberKnife â or TomoTherapy â are not considered here. The scope of this guideline does not include tests for on-board imaging equipment. Imaging tests are essential in a linac QA program and they are addressed in previous reports. [3] [4] [5] Implementation notes are included for each recommended test so that the QMP can understand the overall goal of each test.
However, this guideline is not intended to be a "how to" document. Suggestions will be made on what types of devices are helpful and suitable for measurement, but the choice of measurement equipment and technique is ultimately the responsibility of the QMP.
| INTEN DED USERS
The intended users of this report are QMPs who are conducting linac performance tests or those that are designing a QA program for linacs and seek to understand the critical tests needed to detect errors and ensure safe and high quality external beam radiation therapy delivery.
Administrators, manufacturers of linacs, personnel representing accrediting bodies and state regulators are also encouraged to use this guideline as a reference in understanding an institution's use of equipment and necessary tests chosen by the QMP to maintain the equipment.
The American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose primary purposes are to advance the science, education, and professional practice of medical physics. The AAPM has more than 8000 members and is the principal organization of medical physicists in the United States.
The AAPM will periodically define new practice guidelines for medical physics practice to help advance the science of medical physics and to improve the quality of service to patients throughout the United States. Existing medical physics practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner.
Each medical physics practice guideline represents a policy statement by the AAPM, has undergone a thorough consensus process in which it has been subjected to extensive review, and requires the approval of the Professional
Council. The medical physics practice guidelines recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guidelines and technical standards by those entities not providing these services is not authorized.
The following terms are used in the AAPM practice guidelines:
• Must and Must Not: used to indicate that adherence to the recommendation is considered necessary to conform to this practice guideline.
• Should and Should Not: used to indicate a prudent practice to which exceptions may occasionally be made in appropriate circumstances.
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| STAFF QUALIFICATIONS AND RESPONSIBILITIES
A Qualified Medical Physicist is defined by AAPM Professional Policy 1. 6 The QMP shall be able to independently perform all of the required duties in the field of therapeutic medical physics, including designing and maintaining an overall QA program.
The QMP must design and direct all QA activities, aid in the performance of tests or analysis if needed and assume professional responsibility for the work done. 7 The QMP may delegate certain QA responsibilities to qualified personnel. The QMP is responsible for reviewing and promulgating the outcome of tests and ensuring that the results are meeting set tolerances.
| DEFIN ITIONS AND ABBREVIATIONS

5.A | Abbreviations
3D Conformal, three-dimensional conformal radiation therapy.
AAPM, American Association of Physicists in Medicine.
CAX, central axis.
CBCT, cone-beam computed tomography.
D, (lack of detectability) probability of not detecting a failure; as used in FMEA analysis.
DICOM, digital imaging and communications in medicine.
DOFs, degrees of freedom.
EPID, electronic portal imaging device.
FMEA, failure mode and effects analysis.
IEC, International Electrotechnical Commission.
IGRT, image guided radiation therapy.
IMRT, intensity modulated radiation therapy.
MLC, multi-leaf collimator.
MU, monitor unit.
O, (occurrence) frequency of failure; as used in FMEA analysis.
OAF, off-axis factor.
ODI, optical distance indicator.
PDD, percent depth dose.
QA, quality assurance.
QMP, qualified medical physicist.
RPN, risk priority number.
S, (severity) the severity of a failure; as used in FMEA analysis.
SBRT, stereotactic body radiation therapy.
SRS, stereotactic radiosurgery.
SSD, source-to-surface distance.
TBI, total body irradiation.
TPR, tissue phantom ratio.
TPS, treatment planning system.
TSET, total skin electron therapy.
VMAT, volumetric modulated arc therapy. Scoring participants assigned occurrence scores to performance tests using their experience of failure rates for the clinical parameter in question. For example, scoring participants considered how often the optical distance indicator (ODI) test has fallen out of tolerance in their experience.
Scoring participants assigned a severity score to each performance test. In order to assign a severity score, scoring participants assumed that the clinical parameter in question was not being tested at the recommended frequency and was out of tolerance.
We then considered the severity of harm to a patient if the patient were treated with an out of tolerance clinical parameter (e.g., the ODI is off by greater than the tolerance value and therefore the patient's source-to-surface distance (SSD) could be off by the same amount A water tank is typically used for beam measurements at commissioning and annual testing. For more routine measurements, such as profile constancy on a daily or monthly basis, it is easier to use a device other than a water tank. For example, a secondary measurement system may be used for monthly measurements and a tertiary system may be used for daily measurements. In this case, it is necessary to create a reference dataset that has been appropriately verified by TPS data or compared to an absolute standard. An effective approach for creating a routine reference dataset (or creating a baseline) is outlined in the process below:
• Perform annual beam measurements
• Compare results of annual measurements to TPS data, commissioning data that are verified by TPS data, or absolute standards (TG51 calibration standards)
• Ensure results are within acceptable tolerance and resolve differences (if any)
• Once annual beam measurements are verified, make measurements with the routine device/method (secondary and tertiary measurement systems). Ideally, this occurs in the same measurement session on the same day. The data acquired from this measurement are now the reference dataset that effectively becomes the baseline for comparison for routine measurements.
It is the responsibility of the QMP to ensure that all reference datasets are appropriately used and verified against absolute standards (i.e., the TPS) on at least an annual basis.
8.B | Isocenter
One critical piece of reference data that is not in the TPS is the loca- 
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It is also common to use C-arm linacs to treat patients with a stereotactic radiosurgery (SRS) or a hypofractionated [stereotactic body radiation therapy (SBRT)] treatment regimen. 17, 18 In this clinical setting, the QMP should refer to protocols specifically designed for performance tests in a stereotactic setting in order to achieve a higher degree of accuracy than that needed for regularly fractionated patients. 19, 20 In addition, the QMP may choose to do additional testing (i.e., Winston-Lutz test) on the day of the treatment for stereotactic/hypofractionated treatments to ensure that the mechanical alignment of the radiation isocenter is appropriate for such patients.
8.D. | Vendor provided tests and tools
Many equipment vendors provide recommended QA and safety tests for their equipment. These tests may be a useful reference for the QMP, who should be familiar with the recommendations. However, it is the responsibility of the QMP to evaluate which of these tests are appropriate for their institution and the usage of each machine.
Also, vendor tests are rarely a complete, comprehensive set of tests. 
8.E | Performance tests after maintenance
There are some tests that should be performed after general or specific maintenance on an accelerator to ensure that clinical parameters have not changed either intentionally or inadvertently. Daily-this frequency implies that a specific test only needs to be done on the day the function is used.
Tolerance-all tolerances are listed as "within X% or within X mm" and they are listed to mean that the tolerance should be within AEX% or AEX mm of the standard or baseline. When a tolerance is listed as a percent change from a value (e.g., 2% of PDD), it indicates a relative change from the original value.
D | Dosimetry tests D1 | Photon and electron output constancy
Photon and electron beam output measurements had the highest RPN scores in the risk assessment. Therefore, it is recommended that output be measured daily, monthly, and annually.
• Daily and monthly output checks should be performed on all clinically used beams, and should fall within 3% and 2% of that system's baseline values, respectively. Daily checks may be restricted to the beams in clinical use for that day, at the discretion of the QMP. Readings outside these tolerances should be reported to the QMP to resolve the discrepancies and determine the appropriate course of action.
• Annually, output measurements must be performed in accordance with TG51 (or successor): in water with equipment calibrated by an accredited secondary standards laboratory within the previous 2 yr. Output for each beam must be within 1% of dose calculated via TG51 formalism. It is also recommended that the absolute calibration be externally validated.
• Once the beams are calibrated per TG51, secondary (monthly, if applicable) and tertiary (daily) measurement systems should then be irradiated to establish or confirm baseline output readings that are tied to the primary calibration (refer to section 8.A. of this report). The QMP may use a secondary measurement system (i.e., solid water based) for monthly output checks or use a waterbased system as done for annual calibration. The QMP must decide on the details of secondary and tertiary measurement systems; their fundamental attribute should be reproducibility.
The concept of acquiring or confirming annual baselines of secondary and tertiary measurement systems is described in detail of section 8.A of this report and shall also be applied to checks that follow: beam profile checks (D2) and beam energy checks (D3 and D4).
D2 | Photon and electron beam profile constancy
• Most devices designed for daily output measurements also measure off-axis constancy at one or more points in the radial and • On a monthly basis, the QMP shall review the daily off-axis measurements or measure beam profile shape with another device or method.
• Annual measurements of the beam profile must agree with offaxis points in the TPS. Agreement of off-axis points must be within 2% within the central 80% of beam as compared to the TPS data. The QMP should refer to MPPG5a for TPS commissioning recommendations. 21 For geometries where the TPS model comparison to measured data is slightly greater than 2% due to modeling inaccuracies, the tolerance should be the same as what was achievable at the time of commissioning.
• A review by committee members of daily and annual profile mea- 
D3 | Electron beam energy
• Most daily measurement devices also measure electron energy constancy. On a monthly basis, the QMP shall review the daily energy measurements. The QMP may choose to take additional measurements with a second method, such as measurement at two depths in a phantom.
• Annual measurements of electron beam energy may be point measurements to verify I50 or R50 or measure a full ionization curve. If the I50/R50 measurement detects a change in energy, a full depth scan must be performed in water and if changes are found, the beam must be adjusted or recommissioned as needed.
D4 | Photon beam energy
• Most daily measurement devices also measure photon energy constancy. On a monthly basis, the QMP shall review the daily energy measurements. The QMP may choose to take additional measurements with a second method, such as measurement at two depths in a phantom.
• Annual measurements of photon beam energy may be point measurements or a full depth dose curve in water. At a minimum, the QMP must verify the PDD 10X value used in TG51 calculations.
Alternate measurements could be done to abide by any successive calibration protocol.
• Changes in OAFs have recently been shown to also be an indicator of photon energy change. 22, 23 The QMP must choose the most appropriate method to monitor beam energy; however, the QMP must have full knowledge of the relationship between OAF changes or changes in PDD as it relates to changes in beam energy. Static field MU linearity should be checked using the MU set on the accelerator down to the lowest clinically used MU setting. 
D5 | Dynamic delivery control
D10 | Photon and electron OAF vs gantry angle
As with output, OAF vs gantry angle can be a challenge to measure.
A gantry mounted measurement system is very helpful, but not always available. Annually, the QMP should test clinically relevant angles for the facility. Single point measurements at some distance off-axis (e.g., 10-15 cm) can be performed if an array is not available. Points off-axis should agree with values at IEC gantry 0 o to within 2%.
D11 | Arc mode (expected MU, degree)
This test is required annually if arc mode is used in a manner other than with dynamic deliveries (i.e., VMAT) such as static field arcs.
This test must be performed for each energy and dose rate used clinically with arcs. The tolerance is 2% of the total MU of the arc and 2°over entire arc. If arcs are only used with VMAT deliveries and the QMP is doing VMAT patient specific QA and test D5, this test is not required.
D12 | Special Procedure Mode (TBI/TSET)
Annually, critical clinical parameters used with any special procedures such as total body irradiation (TBI) and total skin electron therapy (TSET) should be tested. At a minimum, output, energy and OAFs should be verified for each special procedure mode at the clinical geometry with accessories in place. Testing accessories independently is not required if accessories are validated by using them in the measurement. Any special procedure mode not maintained for clinical use must be decommissioned.
M | Mechanical tests M1 | Localizing lasers
Many clinical facilities rely much less on lasers for patient setup than in years past due to daily image guided radiation therapy (IGRT) use.
The QMP must determine the frequency and tolerances for laser tests. For example, the frequency and tolerance of testing for a treatment room that uses lasers as initial setup prior to IGRT should be less stringent than a room that sets up SRS patients for treatment with the lasers. Highly accurate SRS lasers should be verified by a more precise Winston-Lutz test as part of pretreatment patient QA thus we provide no specific tolerances for this use case. The tolerances should be specified by the QMP based on their uses.
M2 | Optical distance indicator
Daily checks should include at least a check of the ODI at a single distance, typically 100 cm. Monthly checks should be done at multiple, clinically relevant distances, using whatever device the QMP deems appropriate (examples: mechanical front pointer, digital couch readouts). The tolerance should be 2 mm or the precision of the reading.
M3 | Jaw position indicators
Individual jaw positions should be tested. Positions are typically checked daily with a single square field ( At a minimum, the light to radiation field congruence should be verified after service to the mirror, field light bulb, or any work on the treatment head that may inadvertently affect the bulb or any component of the optical system.
M5 | Leaf position accuracy
Positional accuracy of all leaves (and backup jaws, if applicable) should be checked monthly. It is the responsibility of the QMP to understand the MLC positioning system and decide which test is appropriate. The test should be performed at different gantry angles to detect any gravity-induced positional errors. An acceptable test includes a Picket
Fence-type test. 27, 28 Other tests that are tailored to the design of Elekta and Siemens MLC systems also exist (Hancock for Elekta and the Diamond jig system for Siemens). Leaves should move to prescribed positions to within 1 mm for clinically relevant positions.
M6 | Gantry and collimator angle indicators
Test gantry and collimator angle readouts monthly at cardinal angles.
If the imaging system uses a separate gantry encoder, it should be checked as well.
M7 | Physical graticule
The port film graticule and digital graticules are used for different • 
M13 | Accessory latches/interfaces (all slots)
Annually, verify that any accessory that mounts to the linac head latches properly and will not be dislodged or move in a way that will clinically affect the dose distribution position as the gantry rotates.
This test is included to verify accessories that may not be included in M11, M12, or W2 (e.g., the block tray).
The functionality of the door interlock should be checked daily to ensure that the radiation beam will terminate if the door is opened.
S2 | Door closing safety
The QMP should ensure that the door is able to function in a safe manner when staff and patients enter and exit a treatment room. At a minimum, this test should be completed after regular service or any maintenance to the door. The QMP must consider testing the emergency opening options (e.g., battery backup, come-along, etc.)
for sliding doors or heavy swing doors. The QMP may determine an alternative frequency for this test based on the type of door and its opening design.
S3 | Audio/visual monitors
The functionality of the audio and visual monitoring systems of the patient should be checked daily. At least one channel of audio and one channel of video monitoring are required for clinical use of the machine.
S4 | Beam-on indicators
The functionality of beam-on indicators at the console and the door should be checked daily. All beam-on indicators (inside and outside the vault) should be checked annually.
S5 | Anti-collision test
A single anti-collision device should be checked daily for system function and each point may be rotated. All anti-collision devices should be checked for functionality monthly if used clinically. These include laser guards and touch guards for imaging arms and the electronic portal imaging device (EPID). Electron cone touch guards are also checked annually in test M11.
S6 | Safety procedures
The QMP should use knowledge and experience to determine a set of safety tests and the frequency that is necessary. These tests should be relative to clinical practice and technology used. The QMP may refer to manufacturer's guidelines and/or state regulations to determine which tests are appropriate; however, the QMP should decide on how these tests are implemented clinically.
W | Wedge tests
Definitions:
Physical Wedge-this term is used to describe a wedge that latches on to an accessory tray attached to the treatment head.
Internal Physical Wedge-this term is used to describe a wedge which is mounted and moves inside the treatment head (Universal wedge).
Collimator Shaped Wedge-this term is used to describe wedges formed by a moving collimator (Dynamic or Virtual wedge).
Electronic Wedge-this term is used to describe all internal physical wedges AND all collimator shaped wedges.
W1 | Electronic wedge check
• The daily test for an internal physical wedge may be either a functional test that the wedge moves properly into the beam or an output measurement with the wedge in the beam. For collimator shaped wedges, it is recommended that the output be checked with the daily device to within 3% for the steepest wedge angle.
• Monthly, the QMP should review the daily wedge output results and investigate results that are consistently greater than 2% of expected. If daily output measurements are not made on the internal physical wedge, a monthly wedge factor should be measured with a tolerance of 2%.
W2 | Physical wedge placement accuracy 
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